A trial of ipatasertib, paclitaxel and atezolizumab for breast cancer

This trial is looking at ipatasertib, paclitaxel and atezolizumab for breast cancer that has spread to another part of the body (advanced breast cancer).

It is for people with advanced breast cancer that has:

• no receptors for the hormones oestrogen and progesterone or the protein HER2 (triple negative breast cancer) OR

• receptors for the hormones oestrogen and, or progesterone and there are none or few receptors for the HER2 protein (hormone positive/HER2 negative breast cancer)